Annual Working Capital
$520.17 M
-$94.10 M-15.32%
December 31, 2023
Summary
- As of February 7, 2025, LYEL annual working capital is $520.17 million, with the most recent change of -$94.10 million (-15.32%) on December 31, 2023.
- During the last 3 years, LYEL annual working capital has fallen by -$48.09 million (-8.46%).
- LYEL annual working capital is now -15.32% below its all-time high of $614.27 million, reached on December 31, 2022.
Performance
LYEL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$416.53 M
-$52.41 M-11.18%
September 30, 2024
Summary
- As of February 7, 2025, LYEL quarterly working capital is $416.53 million, with the most recent change of -$52.41 million (-11.18%) on September 30, 2024.
- Over the past year, LYEL quarterly working capital has dropped by -$103.63 million (-19.92%).
- LYEL quarterly working capital is now -45.99% below its all-time high of $771.18 million, reached on June 30, 2021.
Performance
LYEL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
LYEL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | -19.9% |
| 3 y3 years | -8.5% | -28.1% |
| 5 y5 years | +24.4% | -46.0% |
LYEL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.3% | at low | -32.4% | at low |
| 5 y | 5-year | -15.3% | +24.4% | -46.0% | at low |
| alltime | all time | -15.3% | +24.4% | -46.0% | at low |
Lyell Immunopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $416.53 M(-11.2%) |
| Jun 2024 | - | $468.94 M(-6.5%) |
| Mar 2024 | - | $501.81 M(-3.5%) |
| Dec 2023 | $520.17 M(-15.3%) | $520.17 M(-5.7%) |
| Sep 2023 | - | $551.79 M(-3.5%) |
| Jun 2023 | - | $572.02 M(-3.6%) |
| Mar 2023 | - | $593.60 M(-3.4%) |
| Dec 2022 | $614.27 M | $614.27 M(+0.9%) |
| Sep 2022 | - | $608.53 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $616.49 M(+5.4%) |
| Mar 2022 | - | $584.65 M(+0.9%) |
| Dec 2021 | $579.55 M(+2.0%) | $579.55 M(+1.3%) |
| Sep 2021 | - | $571.87 M(-25.8%) |
| Jun 2021 | - | $771.18 M(+39.5%) |
| Mar 2021 | - | $552.92 M(-2.7%) |
| Dec 2020 | $568.26 M(+35.9%) | - |
| Dec 2020 | - | $568.26 M |
| Dec 2019 | $418.21 M | - |
FAQ
- What is Lyell Immunopharma annual working capital?
- What is the all time high annual working capital for Lyell Immunopharma?
- What is Lyell Immunopharma annual working capital year-on-year change?
- What is Lyell Immunopharma quarterly working capital?
- What is the all time high quarterly working capital for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly working capital year-on-year change?
What is Lyell Immunopharma annual working capital?
The current annual working capital of LYEL is $520.17 M
What is the all time high annual working capital for Lyell Immunopharma?
Lyell Immunopharma all-time high annual working capital is $614.27 M
What is Lyell Immunopharma annual working capital year-on-year change?
Over the past year, LYEL annual working capital has changed by -$94.10 M (-15.32%)
What is Lyell Immunopharma quarterly working capital?
The current quarterly working capital of LYEL is $416.53 M
What is the all time high quarterly working capital for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly working capital is $771.18 M
What is Lyell Immunopharma quarterly working capital year-on-year change?
Over the past year, LYEL quarterly working capital has changed by -$103.63 M (-19.92%)